Novartis gains cancer targets but no new tech in CoStim acquisition
Novartis says the acquisition of Massachusetts-based biotech firm CoStim will accelerate its cancer immunotherapy programme but will not add any new technology.
Archives for February 18, 2014
Shire's single-use MA plant receives US FDA approval to make VPRIV
The US Food and Drug Administration (FDA) has approved a second facility for Shire to manufacture its Gaucher disease drug VPRIV.
Fight for Life: new Thermo Fisher acquisition loses out in India
Life Technologies has had its efforts to stop an Indian namesake using certain trademarks and web domains thrown out by the Delhi High Court.